The Peripheral Nerve Society is an international non-profit organization of scientists, physicians, and other healthcare providers working together to investigate and treat diseases of the peripheral nervous system.
To improve the lives of people with peripheral neuropathies.
We support basic and clinical research, education, and standards of care in cooperation with patients and those developing treatments.
PNS abstract submission is now closed. We thank all those that submitted abstracts for the PNS 2022 Annual Meeting in Miami, Florida. The PNS received a total of 357 abstracts from authors in 34 different countries. Abstract notifications will be sent on Tuesday, 29 March.
We are excited to announce the launch of the 2022 PNS Annual Meeting – Miami website. It is a resource for the most up to date information on the 2022 Annual Meeting. Click here to view.
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Read the guideline here. For more information on the new CIDP guideline, please join us on 27 October for an open access webinar presented by Dr. Peter Van Den Bergh. Click here for more information and to register.
The Nerve Connect, the quarterly newsletter of the Peripheral Nerve Society, features the most current activities and initiatives of the Society, spotlights our members and their amazing work, and highlights exciting news in the field of peripheral. Click here to login to your PNS member account to read past issues!
Patients affected by inflammatory PNS disorders, most notably Guillain-Barre syndrome (GBS), and their physicians are making enquiries to the PNS membership about the merits of receiving a COVID vaccination. The following commentary on this complex issue has been recently published by a team of PNS members, led by Professor Michael Lunn, which summaries the current evidence surrounding vaccination and GBS: https://doi.org/10.1093/brain/awaa444. For additional information on COVID-19 vaccines and the GBS|CIDP community, please click here.